NR4A1 and neoplasm: These likely indicate a reduction or loss of tumor sub-clones during from PT to IBTR, but did not associate with hormonal receptor status or other clinical variables with the exception of weak positive relationships with age at diagnosis of PT (Spearman Rho = 0.295) and IBTRFS (Spearman Rho = 0.372).